[
  {
    "ts": "2026-02-10T11:47:00+00:00",
    "headline": "Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results;  Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2025.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-reports-fourth-quarter-114700868.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2d248552-2708-3c22-a557-31db4c3d7e58",
      "content": {
        "id": "2d248552-2708-3c22-a557-31db4c3d7e58",
        "contentType": "STORY",
        "title": "Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results;  Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share",
        "description": "",
        "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2025.",
        "pubDate": "2026-02-10T11:47:00Z",
        "displayTime": "2026-02-10T11:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "questhealth.com logo (PRNewsfoto/Quest Diagnostics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v6s3D2c6OzmZrj.0kIY12Q--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFrizODjj_bBgmzRgIgaqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-reports-fourth-quarter-114700868.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-reports-fourth-quarter-114700868.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T11:33:00+00:00",
    "headline": "Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the Company's Board of Directors has authorized a 7.5% increase in its quarterly cash dividend to $0.86 per share from $0.80 per share. The increase is effective with the dividend payable on April 20, 2026 to shareholders of record of Quest Diagnostics common stock on April 6, 2026. With the increase, the annual cash dividend will be $3.44 per share.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-increases-dividend-7-113300933.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "7cf75a55-8ff1-3d61-8438-aadb49fd3416",
      "content": {
        "id": "7cf75a55-8ff1-3d61-8438-aadb49fd3416",
        "contentType": "STORY",
        "title": "Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization",
        "description": "",
        "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the Company's Board of Directors has authorized a 7.5% increase in its quarterly cash dividend to $0.86 per share from $0.80 per share. The increase is effective with the dividend payable on April 20, 2026 to shareholders of record of Quest Diagnostics common stock on April 6, 2026. With the increase, the annual cash dividend will be $3.44 per share.",
        "pubDate": "2026-02-10T11:33:00Z",
        "displayTime": "2026-02-10T11:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "questhealth.com logo (PRNewsfoto/Quest Diagnostics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v6s3D2c6OzmZrj.0kIY12Q--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFrizODjj_bBgmzRgIgaqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-increases-dividend-7-113300933.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-increases-dividend-7-113300933.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T12:06:13+00:00",
    "headline": "Quest Diagnostics: Q4 Earnings Snapshot",
    "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $2.35 per share. The medical laboratory operator posted revenue of $2.81 billion in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $2.75 billion.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-snapshot-120613506.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "a96c89b6-b20a-3992-a802-7948c61200e8",
      "content": {
        "id": "a96c89b6-b20a-3992-a802-7948c61200e8",
        "contentType": "STORY",
        "title": "Quest Diagnostics: Q4 Earnings Snapshot",
        "description": "",
        "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $2.35 per share. The medical laboratory operator posted revenue of $2.81 billion in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $2.75 billion.",
        "pubDate": "2026-02-10T12:06:13Z",
        "displayTime": "2026-02-10T12:06:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-snapshot-120613506.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-snapshot-120613506.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T11:58:22+00:00",
    "headline": "Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue",
    "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q4 CY2025, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue guidance of $11.76 billion at the midpoint came in 3.3% above analysts’ estimates. Its non-GAAP profit of $2.42 per share was 2.6% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/quest-nyse-dgx-q4-cy2025-115822596.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c7c5a0da-9046-3218-9ee5-32b3cf60c249",
      "content": {
        "id": "c7c5a0da-9046-3218-9ee5-32b3cf60c249",
        "contentType": "STORY",
        "title": "Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue",
        "description": "",
        "summary": "Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q4 CY2025, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue guidance of $11.76 billion at the midpoint came in 3.3% above analysts’ estimates. Its non-GAAP profit of $2.42 per share was 2.6% above analysts’ consensus estimates.",
        "pubDate": "2026-02-10T11:58:22Z",
        "displayTime": "2026-02-10T11:58:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DGX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aeh65E_EG08O8chSqy1MVw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l7C10YsggYCA0fc.htm8Ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a002c113304d0049242cefeebcf6d343.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-nyse-dgx-q4-cy2025-115822596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-nyse-dgx-q4-cy2025-115822596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T12:55:02+00:00",
    "headline": "Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates",
    "summary": "Quest Diagnostics (DGX) delivered earnings and revenue surprises of +2.85% and +2.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-beats-q4-125502053.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6338561d-e96b-355e-8683-bfc9e5598122",
      "content": {
        "id": "6338561d-e96b-355e-8683-bfc9e5598122",
        "contentType": "STORY",
        "title": "Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates",
        "description": "",
        "summary": "Quest Diagnostics (DGX) delivered earnings and revenue surprises of +2.85% and +2.08%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-10T12:55:02Z",
        "displayTime": "2026-02-10T12:55:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SVlgtyKcqJmTvHzvwqjZfA--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KqPU5XU5bEHAxdnZQ3L5g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-beats-q4-125502053.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-beats-q4-125502053.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T16:31:03+00:00",
    "headline": "Quest Diagnostics (DGX) Earnings Call Transcript",
    "summary": "With diligent execution of our strategy and a strong fourth quarter, we generated double-digit growth in revenues and earnings per share for the full year.  In 2025, we expanded our category-defining clinical innovation to meet robust demand, formed strategic collaborations with elite health care organizations, and further advanced our position as the premier lab engine powering the wellness industry.  As we look ahead to 2026, our guidance reflects our continued confidence in our business strengths and market fundamentals, which include favorable demographic trends, increasing use of blood-based lab diagnostics, and growing interest in preventative health and wellness.",
    "url": "https://www.fool.com/earnings/call-transcripts/2026/02/10/quest-diagnostics-dgx-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "9198d1fc-cc81-350f-8572-cc0b3bd6824f",
      "content": {
        "id": "9198d1fc-cc81-350f-8572-cc0b3bd6824f",
        "contentType": "STORY",
        "title": "Quest Diagnostics (DGX) Earnings Call Transcript",
        "description": "",
        "summary": "With diligent execution of our strategy and a strong fourth quarter, we generated double-digit growth in revenues and earnings per share for the full year.  In 2025, we expanded our category-defining clinical innovation to meet robust demand, formed strategic collaborations with elite health care organizations, and further advanced our position as the premier lab engine powering the wellness industry.  As we look ahead to 2026, our guidance reflects our continued confidence in our business strengths and market fundamentals, which include favorable demographic trends, increasing use of blood-based lab diagnostics, and growing interest in preventative health and wellness.",
        "pubDate": "2026-02-10T16:31:03Z",
        "displayTime": "2026-02-10T16:31:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2026/02/10/quest-diagnostics-dgx-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-dgx-earnings-call-163103894.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-10T15:43:00+00:00",
    "headline": "Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up",
    "summary": "DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-revenues-154300610.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c2692f62-d236-39aa-b842-39c306538baf",
      "content": {
        "id": "c2692f62-d236-39aa-b842-39c306538baf",
        "contentType": "STORY",
        "title": "Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up",
        "description": "",
        "summary": "DGX tops Q4 EPS and revenue estimates as volumes rise, shares jump premarket, and 2026 guidance points to steady growth.",
        "pubDate": "2026-02-10T15:43:00Z",
        "displayTime": "2026-02-10T15:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-revenues-154300610.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-q4-earnings-revenues-154300610.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "NVST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]